Potency, selectivity and cell cycle dependence of catechols in human tumour cells in vitro
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (9) , 1711-1715
- https://doi.org/10.1016/0006-2952(88)90433-9
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The Cytotoxicity of Cysteinylcatechols and Related Compounds to Human Melanoma Cells In VitroJournal of Investigative Dermatology, 1987
- Modification of dopa toxicity in human tumour cellsBiochemical Pharmacology, 1985
- Anticarcinoma Activity in Vivo of Rhodamine 123, a Mitochondrial-Specific DyeScience, 1983
- 3,4-Dihydroxybenzylamine: An Improved Dopamine Analog Cytotoxic for Melanoma Cells in Part Through Oxidation Products Inhibitory to DNA PolymeraseJournal of Investigative Dermatology, 1983
- Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agentsAdvances in Enzyme Regulation, 1981
- L-Dopa methyl ester as a new antitumour agentNature, 1977
- Biological Role of Xanthine Oxidase and Tetrazolium‐Reductase InhibitorEuropean Journal of Biochemistry, 1973
- Antitumour activity of dopa, dopamine, noradrenalin or adrenalin and their reaction with nucleic acidsZeitschrift für Krebsforschung und Klinische Onkologie, 1970
- THE CYTOTOXICITY OF MELANIN PRECURSORS*Annals of the New York Academy of Sciences, 1963
- Changes in X-ray Sensitivity of HeLa Cells during the Division CycleNature, 1961